UK markets closed

Addex Therapeutics Ltd (ADXN.SW)

Swiss - Swiss Delayed price. Currency in CHF
Add to watchlist
0.0650-0.0010 (-1.52%)
At close: 05:30PM CEST
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Total revenue
1,346
1,613
1,422
2,916
3,613
-
Cost of revenue
-
-
-
-
-
230.097
Gross profit
-
-
-
-
-
2,533
Operating expenses
Research development
2,728
2,748
10,030
9,014
10,373
-
Selling general and administrative
7,272
7,205
10,116
7,746
5,749
-
Total operating expenses
12,047
11,894
21,942
18,422
15,856
-
Operating income or loss
-10,702
-10,281
-20,520
-15,506
-12,243
-
Interest expense
21.609
21.607
48.897
63.012
69.502
-
Total other income/expenses net
-245.761
-317.285
-264.36
211.693
-581.128
-
Income before tax
-10,921
-10,556
-20,804
-15,352
-12,859
-
Income tax expense
0
0
0
0
0
-
Income from continuing operations
-10,921
-10,556
-20,804
-15,352
-12,859
-
Net income
-11,236
-10,556
-20,804
-15,352
-12,859
-
Net income available to common shareholders
-11,236
-10,556
-20,804
-15,352
-12,859
-
Basic EPS
-0.15
-0.14
-0.46
-0.45
-0.48
-
Diluted EPS
-0.15
-0.14
-0.46
-0.45
-0.48
-
Basic average shares
66,980
74,308
45,185
34,120
26,682
-
Diluted average shares
66,980
74,308
45,185
34,120
26,682
-